A team of scientists at the Keck School of Medicine of USC have found people who vape exhibit similar chemical modifications in their overall genome and in parts of their DNA as people who smoke cigarettes.
Fewer than half of Americans recognize that drinking alcohol, diets high in red meat, diets low in vegetables, fruits and fiber and insufficient physical activity all have a clear link to cancer development, according to the American Institute for Cancer Research's ninth Cancer Risk Awareness Survey.
In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers from MD Anderson Cancer Center demonstrated that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.
A study at MD Anderson Cancer Center showed that circulating tumor cells, a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment.
A study analyzing new evolutionary complexity in uveal melanoma by J. William Harbour was published Jan. 24 in Nature Communications.
University of California San Diego School of Medicine researchers used genetically engineered human pluripotent stem cells to create a cancer model to study in vivo how glioblastoma develops and changes over time.
Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.
The independent data monitoring committee of the phase III SANET-p study of surufatinib in advanced neuroendocrine tumors has recommended that the study end early as the pre-defined primary endpoint of progression free survival had already been met.
Gabapentin is an effective alternative to standard pain-control drugs and can manage head and neck cancer pain and symptoms without the need for narcotics, a study published in Cancer found.
Researchers at Johns Hopkins University have developed an integrated genomic approach that potentially could help physicians predict which patients with non-small cell lung cancer will respond to therapy with immune checkpoint inhibitors.